Sibelium (flunarizine) is a drug classified as a calcium antagonist. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, the vertigo of central and peripheral origin, and as an add-on in the treatment of epilepsy where its effect is weak and not recommended. It has been shown to significantly reduce headache frequency and severity in both adults and children.